[Predictive biomarkers for response to irinotecan, platinum drugs, and taxanes].


Despite extensive progress in basic and translational research, there are few clinically relevant predictive biomarkers for response to conventional chemotherapeutic agents(irinotecan, platinum drugs, taxanes)that can guide in the selection of an optimal chemotherapy regimen. Molecular-targeted drugs are designed to act on specific mutated/overexpressed… (More)


  • Presentations referencing similar topics